Clinical evidence to demonstrate that simultaneous growth of epithelial and fibroblast cells is essential for deep wound healing

Diabetes Research and Clinical Practice

Volumn 92, Issue 1, 2011, Pages 92-99

  Shrivastava, Ravi ^a  

^a ZAC de Lavaur   (France)

Author keywords

AS 21; Deep wound; Plant tannins; Protease activity

Indexed keywords

ALCHEMILLA VULGARIS EXTRACT; GLYCEROL; MIMOSA TENUIFLORA EXTRACT; PLACEBO; PLANT EXTRACT; PROCYANIDIN; TANNIN DERIVATIVE; UNCLASSIFIED DRUG;

AGED; ALCHEMILLA; ALCHEMILLA VULGARIS; APPLICATION SITE IRRITATION; ARTICLE; CELL GROWTH; CHRONIC WOUND; CONTROLLED STUDY; DECUBITUS; DIABETIC FOOT; DRUG EFFICACY; EPITHELIUM CELL; FEMALE; FIBROBLAST; HONEY; HUMAN; INFECTION; LEG ULCER; LEG VARICOSIS; MAJOR CLINICAL STUDY; MALE; MIMOSA; MIMOSA TENUIFLORA; NONHUMAN; PAIN; RANDOMIZED CONTROLLED TRIAL; WOUND HEALING;

ALCHEMILLA; ANIMALS; AZADIRACHTA; CAMELLIA SINENSIS; CATTLE; CELL LINE; CELLS, CULTURED; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; MIMOSA; PANAX; PLANT EXTRACTS; VACCINIUM; VITIS; WOUND HEALING;

EID: 79954612415     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2010.12.021     Document Type: Article

References (44)

1. Jones K.R., Fennie K. Factors influencing pressure ulcer healing in adults over 50: an exploratory study. J Am Med Assoc 2007, 8(6):378-387.
2. Baumgarten M., Margolis D.J., Localio A.R., Kagan S.H., Lowe R.A., Kinosian B., et al. Pressure ulcers among elderly patients in the hospital stay. J Gerontol A 2006, 61:749-754.
3. Claxton M.J., Armstrong D.G., Boulton A.J.M. Healing the diabetic wound and keeping it healed. Curr Diabetes Rep 2002, 2(6):510-518.
4. Fabian W., Majkowska L., Stefański A., Moleda P. Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners. Przegl Lek 2005, 62(4):201-215.
5. Hirschmann J.V. Topical and oral antibiotics in wound care. Cutis 2008, 82(2 (Suppl. 2)):18-20.
6. O'Meara S., Cullum N., Majid M., Sheldon T. Systematic reviews of wound care management: antimicrobial agents for chronic wounds; diabetic foot ulceration. Health Technol Assess 2000, 4(21):1-237.
7. Kruse I., Edelman S. Evaluation and treatment of diabetic foot ulcers. Clin Diabetes 2006, 24:91-93.
8. Stekelenburg A., Gawlitta D., Bader D.L., Oomens C.W. Deep tissue injury: how deep is our understanding?. Arch Phys Med Rehabil 2008, 89(7):1410-14133.
9. Black J., Baharestani M., Cuddigan J., Dorner B., Edsberg L., Langemo D., et al. National pressure ulcer advisory panel's updated pressure ulcer staging system. Dermatol Nurs 2007, 19(4):343-349. quiz 350.
10. Steed D.L. Role of growth factors in the treatment of diabetic foot ulceration. The diabetic foot 2006, pp. 447-458. second ed.
11. Alvarez O.M., Markowitz L., Wendelken M. Local care of diabetic foot ulcers. The diabetic foot 2007, pp. 311-333. second ed.
12. Harding K., Cutting K., Price P. The cost-effectiveness of wound management protocols of care. Brit J Nurs 2001, 10(4):216-217.
13. Fu X., Li X., Cheng B., Chen W., Sheng Z. Engineered growth factors and cutaneous wound healing: success and possible questions in the past 10 years. Wound Repair Regen 2005, 13(2):122-130.
14. Khanna S., Venojarvi M., Roy S., Sharma N., Trikha P., Bagchi D., et al. Dermal wound healing properties of redox-active grape seed proanthocyanidins. Free Radical Biol Med 2002, 33(8):1089-1096.
15. Rivera-Arce E., Chávez-Soto M.A., Herrera-Arellanob A., Arzate S., Aguero J., Feria-Romero I.A., et al. Therapeutic effectiveness of a Mimosa tenuiflora cortex extract in venous leg ulceration treatment. J Ethnopharmacol 2007, 109:523-528.
16. Souza S.M., Aquino L.C., Milach A.C., Bandeira M.A., Nobre M.E., Viana G.S. Antiinflammatory and antiulcer properties of tannins from Myracrodruon urundeuva Allemão (Anacardiaceae) in rodents. Phytother Res 2007, 21(3):220-225.
17. Marja P., Kähkönen, Anu I., Hopia, Heikki J., Vuorela, et al. Antioxidant activity of plant extracts containing phenolic compounds. J Agric Food Chem 1999, 47(10):3954-3962.
18. Shrivastava R., Chevalier A., Slaoui M., John G. An in vitro method using vascular smooth muscle cells to study the effect of compounds on cell proliferation and intracellular lipid accumulation. Methods Find Exp Clin Pharmacol 1993, 15:345-350.
19. Curtis L., Smith Pharmacotherapy of diabetic foot ulcers. J Pharm Pract 2004, 17(1):66-74.
20. Steed D.L. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic ulcer study group. J Vasc Surg 1995, 21(1):79-81.
21. Wieman T.J., Smiell J.M., Su Y. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study. Diabetes Care 1998, 21(5):822-827.
22. Buckley A., Davidson J.M., Kamerath C.D., Woodward S.C. Epidermal growth factor increases granulation tissue formation dose dependently. J Surg Res 1987, 4(4):322-328.
23. Dong X.Q., Xu J., Wang W.C., Luo H., LiangX, Zhang L. Repair effect of diabetic ulcers with recombinant human epidermal growth factor loaded by sustained-release microspheres. Sci China C: Life Sci 2008, 5(11):1039-1044.
24. Tsang M.W., Wong W.K., Hung C.S., Lai K.M., Tang W., Cheung Elaine Y.N Human epidermal growth factor enhances healing of diabetic foot ulcers. Diabetes Care 2003, 26:1856-1861.
25. Bhora F.Y., Dunkin B.J., Batzri S., ALy H.M., Bass B.L., Sidawy A.N., et al. Effect of growth factors on cell proliferation and epithelialization in human skin. J Surg Res 1995, 59:236-244.
26. Papanas N., Maltezos E. Growth factors in the treatment of diabetic foot ulcer: new technologies, any promises?. Int J Lower Extremity Wounds 2007, 6(1):37-53.
27. Brandber J.M., Zacheja S., Houdeck P., Moll I., Lobmann R. Expression of matrix metalloproteinases, cytokines, and connexins in diabetic and nondiabetic human keratinocytes bfore and after transplantation into ex vivo wound-healing model. Diabetes Care 2008, 31:114-120.
28. Agren M.S., Werthen M. The extracellular matrix in wound healing: a closer look at therapeutics for chronic wounds. Int J Lower Extremity Wounds 2007, 6(2):82-97.
29. Lobmann R., Schultz G., Lehnert H. Proteases and the diabetic foot syndrome: mechanisms and therapeutic implications. Diabetes Care 2005, 28:461-471.
30. Lobmann R., Ambrosch A., Schultz G., Waldmann K., Schuweck S., Lehnert H. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Dibetologia 2002, 45:1011-1016.
31. Jonadet M., Meunier M.T., Villie F., Bastide J.P., Lamaison J.L. Flavoniodes extraits de Ribes nigrum L. et d'Alchemilla vulgaris L. J Pharmacol 1986, 17(1):21-27.
32. Shrivastava R. New synergic association for the treatment of deep skin and mucosa injuries. Patent PCT/EP2008/064214; 2008.
33. Maffei Facino R., Carini M., Aldini G., Bombardelli E., Morazzoni P., Morelli R. Free radicals scavening action and anti-enzyme activities of procyanidines from Vitis vinifera. Arzneim Forsch 1994, 44(5):592-601.
34. Tixier J.M., Godeau G., Robert A.M., Hornebeck W. Evidence by in vivo and in vitro studies that binding of pycnogenols to elastin affects its rate of degradation by elastases. Biochem Pharmacol 1984, 33(24):3933-3939.
35. Zhang Y.J., Tanaka T., Betsumyia Y., Jusano R., Matsuo A., Ueda T. Association of tannins and related polyphenols with the cyclic peptide gramicidin S. Chem Pharm Bull 2002, 50(2):258-262.
36. Bos M.A., Vennat B., Meunier M.T., Pouget M.P., Pourrat A., Fialip J. Procyanidins from tormentil: antioxidant properties towards lipoperoxidation and anti-elastase activity. Biol Pharm Bull 1996, 19(1):146-148.
37. Kakegawa H., Matsumoto H., Endo K., Satoh T., Nonaka G., Nishioka I. Inhibitory effects of tannins on hyaluronidase activation and on the degranulation from rat mesentery mast cells. Chem Pharm Bull 1985, 33(11):5079-5082.
38. Lamaison J.L., Carnat A., Petitjean-freytet C. Teneur en tannins et activité inhibitrice de l'élastase chez les Rosaceae. Ann Pharmaceut françaises 1990, 48(6):335-340.
39. Le Bourvellec C., Guyot S., Renard C.M.G.C. Non-covalent interaction between procyanidins and apple cell wall materials: part I. Effect of some environmental parameters. Biochim Biophys Acta 2004, 1672(3):192-202.
40. Williamson M.P., McCornick T.G., Nance C.L., Shearer W.T. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: potential for HIV-1 therapy. J Allergy Clin Immunol 2006, 118:1369-1374.
41. Yarwood S.J., Woodgett J.R. Extracellular matrix composition determines the transcriptional response to epidermal growth factor activation. Proc Natl Acad Sci USA 2000, 98(8):4472-4477.
42. Upadhyay N.K., Kumar R., Mandotra S.K., Meena R.N., Siddiqui M.S., Sawhney R.C., et al. Safety and healing efficacy of sea buckthorn (Hippophae rhamnoides L.) seed oil on burn wounds in rats. Food Chem Toxicol 2009, 47(6):1146-1153.
43. Süntar I.P., Akkol E.K., Yilmazer D., Baykal T., Kirmizibekmez H., Alper M., et al. Investigations on the in vivo wound healing potential of Hypericum perforatum L. J Ethnopharmacol 2010, 3(127 (2)):468-477.
44. Jin-Young Kim, Seong-Cheol Park, Indeok Hwang, Hyeonsook Cheong, Jae-Woon Nah, Kyung-Soo Hahm, et al. Protease inhibitors from plants with antimicrobial activity. Int J Mol Sci 2009, 10(6):2860-2872.